- ►chestpubs.org [PDF] TE Warkentin - Hematology/Oncology Clinics of North America, 2007 - Elsevier Heparin-induced thrombocytopenia (HIT) is an immune-mediated adverse drug effect
that is characterized by platelet activation, hypercoagulability, and a
resulting increased risk for thrombosis, both venous and arterial. This ... Cited by 916 - Related articles - BL Direct - All 40 versions
- ►chestpubs.org J Ansell, J Hirsh, E Hylek, A Jacobson, M … - Chest, 2008 - chestjournal.chestpubs.org This article concerning the pharmacokinetics and pharmacodynamics of vitamin K
antagonists (VKAs) is part of the American College of Chest Physicians
Evidence-Based Clinical Practice Guidelines (8th Edition). It describes the ... Cited by 892 - Related articles - BL Direct - All 21 versions
TE Warkentin, A Greinacher - Chest, 2004 - chestjournal.chestpubs.org This chapter about the recognition, treatment, and prevention of heparin-induced
thrombocytopenia (HIT) is part of the Seventh ACCP Conference on Antithrombotic
and Thrombolytic Therapy: Evidence Based Guidelines. Grade 1 ... Cited by 533 - Related articles - BL Direct - All 17 versions
TE Warkentin - Archives of Pathology and Laboratory Medicine, 2002 - arpa.allenpress.com Archives of Pathology and Laboratory Medicine: Vol. 126, No. 11, pp.
1415–1423. ... Objective.—Heparin-induced thrombocytopenia (HIT) is an
antibody-mediated adverse drug reaction that paradoxically is associated ... Cited by 135 - Related articles - BL Direct - All 4 versions
AF Srinivasan, L Rice, JR Bartholomew, C … - Archives of Internal Medicine, 2004 - archinte.highwire.org Background Heparin-induced thrombocytopenia (HIT) is a common, often
catastrophic, syndrome that produces the most hypercoagulable of states.
Emerging therapeutic strategies use alternative anticoagulants; warfarin's ... Cited by 106 - Related articles - BL Direct - All 7 versions
- ►chestpubs.org TE Warkentin, A Greinacher, A Koster, AM … - Chest, 2008 - chestjournal.chestpubs.org This chapter about the recognition, treatment, and prevention of heparin-induced
thrombocytopenia (HIT) is part of the Antithrombotic and Thrombolytic Therapy:
American College of Chest Physicians Evidence-Based Clinical Practice ... Cited by 105 - Related articles - All 11 versions
TE Warkentin - Thrombosis research, 2003 - Elsevier Heparin-induced thrombocytopenia (HIT) is a transient hypercoagulability state
initiated, paradoxically, by the anticoagulant, heparin. It is characterized by
antibody-induced activation of platelets, leading to thrombin generation. ... Cited by 85 - Related articles - All 11 versions
- ►hematologylibrary.org TE Warkentin, WC Aird, JH Rand - Hematology, 2003 - asheducationbook.hematologylibrary.org In Section II, Dr. Theodore Warkentin describes HIT as a clinicopathologic
syndrome, ie, the diagnosis should be based on the concurrence of an appropriate
clinical picture together with detection of platelet-activating and/or ... Cited by 79 - Related articles - All 4 versions
N Lubenow, P Eichler, T Lietz, A Greinacher - Journal of Thrombosis and Haemostasis, 2005 - ingentaconnect.com Objectives: To assess efficacy and safety of lepirudin in patients with
heparin-induced thrombocytopenia (HIT) in a prospective study (HAT-3) as well as
in a combined analysis of all HAT study data. Patients/methods: Patients ... Cited by 68 - Related articles - BL Direct - All 2 versions
MA Smythe, TE Warkentin, JL Stephens, D … - American journal of hematology, 2002 - interscience.wiley.com We report two patients with deep-vein thrombosis complicating immune
heparin-induced thrombocytopenia who developed venous limb gangrene during
overlapping therapy with a direct thrombin inhibitor (lepirudin or ... Cited by 65 - Related articles - BL Direct - All 5 versions
